The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To investigate whether filaggrin gene defects, present in up to one in 10 western Europeans and North Americans, increase the risk of developing allergic sensitisation and allergic disorders. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, ISI Science Citation Index, BIOSIS, ISI Web of Knowledge, UK National Research Register, clinical trials.gov, the Index to Theses and Digital dissertations, and grey literature using OpenSIGLE. STUDY SELECTION: Genetic epidemiological studies (family, case-control) of the association between filaggrin gene defects and allergic sensitisation or allergic disorders. DATA EXTRACTION: Atopic eczema or dermatitis, food allergy, asthma, allergic rhinitis, and anaphylaxis, along with relevant immunological variables relating to the risk of allergic sensitisation as assessed by either positive skin prick testing or increased levels of allergen specific IgE. DATA SYNTHESIS: 24 studies were included. The odds of developing allergic sensitisation was 1.91 (95% confidence interval 1.44 to 2.54) in the family studies and 1.57 (1.20 to 2.07) in the case-control studies. The odds of developing atopic eczema was 1.99 (1.72 to 2.31) in the family studies and 4.78 (3.31 to 6.92) in the case-control studies. Three studies investigated the association between filaggrin gene mutations and allergic rhinitis in people without atopic eczema: overall odds ratio 1.78 (1.16 to 2.73). The four studies that investigated the association between filaggrin gene mutations and allergic rhinitis in people with atopic eczema reported a significant association: pooled odds ratio from case-control studies 2.84 (2.08 to 3.88). An overall odds ratio for the association between filaggrin gene mutations and asthma in people with atopic eczema was 2.79 (1.77 to 4.41) in case-control studies and 2.30 (1.66 to 3.18) in family studies. None of the studies that investigated filaggrin gene mutations and asthma in people without atopic eczema reported a significant association; overall odds ratio was 1.30 (0.7 to 2.30) in the case-control studies. The funnel plots suggested that publication bias was unlikely to be an explanation for these findings. No studies investigated the association between filaggrin gene mutations and food allergy or anaphylaxis. CONCLUSIONS: Filaggrin gene defects increase the risk of developing allergic sensitisation, atopic eczema, and allergic rhinitis. Evidence of the relation between filaggrin gene mutations and atopic eczema was strong, with people manifesting increased severity and persistence of disease. Filaggrin gene mutations also increased the risk of asthma in people with atopic eczema. Restoring skin barrier function in filaggrin deficient people in early life may help prevent the development of sensitisation and halt the development and progression of allergic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Life Course Approach to Chronic Disease Epidemiology
(2004) · doi:10.1093/acprof:oso/9780198578154.001.0001 · Cited by 1,984
The case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034
Spergel, J. M., Mizoguchi, E., Brewer, J. P., Martin, T. R., Bhan, A. K., & Geha, R. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1647 · Cited by 640
Time trends in allergic disorders in the UK
Gupta, R., Sheikh, A., Strachan, D. P., & Anderson, H. R. (2007) · Thorax · doi:10.1136/thx.2004.038844 · Cited by 476
Self-citationFamily-based designs in the age of large-scale gene-association studies
Laird, N. M., & Lange, C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1839 · Cited by 450
Filaggrin in atopic dermatitis
O'Regan, G. M., Sandilands, A., McLean, W. H. I., & Irvine, A. D. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.013 · Cited by 443
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
Little, J., Bradley, L., Bray, M. S., Clyne, M., Dorman, J., Ellsworth, D. L., Hanson, J., Khoury, M., Lau, J., O'Brien, T. R., et al. (2002) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a000179 · Cited by 370
Burden of allergic disease in the UK: secondary analyses of national databases
Gupta, R., Sheikh, A., Strachan, D. P., & Anderson, H. R. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1935.x · Cited by 352
Self-citation
Cited by
Boyce, J. A., Assa'ad, A., Burks, A. W., Jones, S. M., Sampson, H. A., Wood, R. A., Plaut, M., Cooper, S. F., Fenton, M. J., Arshad, S. H., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.008 · Cited by 2,350
(2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.007 · Cited by 1,267
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,073
Greiner, A. N., Hellings, P. W., Rotiroti, G., & Scadding, G. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60130-x · Cited by 895
Food allergy: A practice parameter update—2014
Sampson, H. A., Aceves, S., Bock, S. A., James, J., Jones, S., Lang, D., Nadeau, K., Nowak-Wegrzyn, A., Oppenheimer, J., Perry, T. T., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.013 · Cited by 845
The Skin Prick Test—European Standards
Heinzerling, L., Mari, A., Bergmann, K., Bresciani, M., Burbach, G., Darsow, U., Durham, S., Fokkens, W., Gjomarkaj, M., Haahtela, T., et al. (2013) · Clinical and Translational Allergy · doi:10.1186/2045-7022-3-3 · Cited by 681
Atopic dermatitis endotypes and implications for targeted therapeutics
Czarnowicki, T., He, H., Krueger, J. G., & Guttman-Yassky, E. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.032 · Cited by 631
Application of moisturizer to neonates prevents development of atopic dermatitis
Horimukai, K., Morita, K., Narita, M., Kondo, M., Kitazawa, H., Nozaki, M., Shigematsu, Y., Yoshida, K., Niizeki, H., Motomura, K.-I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.060 · Cited by 607
Deckers, I. A. G., McLean, S., Linssen, S., Mommers, M., van Schayck, C. P., & Sheikh, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039803 · Cited by 558
Self-citationOne remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
Brown, S. J., Asai, Y., Cordell, H. J., Campbell, L. E., Zhao, Y., Liao, H., Northstone, K., Henderson, J., Alizadehfar, R., Ben-Shoshan, M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.031 · Cited by 477
IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
Liu, F.-T., Goodarzi, H., & Chen, H.-Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8252-4 · Cited by 470
Thymic stromal lymphopoietin–elicited basophil responses promote eosinophilic esophagitis
Noti, M., Wojno, E. D. T., Kim, B. S., Siracusa, M. C., Giacomin, P. R., Nair, M. G., Benitez, A. J., Ruymann, K. R., Muir, A. B., Hill, D. A., et al. (2013) · Nature Medicine · doi:10.1038/nm.3281 · Cited by 422
The multifunctional role of filaggrin in allergic skin disease
McAleer, M. A., & Irvine, A. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.668 · Cited by 419
Chng, K. R., Tay, A. S. L., Li, C., Ng, A. H. Q., Wang, J., Suri, B. K., Matta, S. A., McGovern, N., Janela, B., Wong, X. F. C. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.106 · Cited by 388
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
Thyssen, J. P., & Kezic, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.014 · Cited by 396
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Dainichi, T., Kitoh, A., Otsuka, A., Nakajima, S., Nomura, T., Kaplan, D. H., & Kabashima, K. (2018) · Nature Immunology · doi:10.1038/s41590-018-0256-2 · Cited by 395
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
Guttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.053 · Cited by 384
Skin Barrier Disruption: A Requirement for Allergen Sensitization?
De Benedetto, A., Kubo, A., & Beck, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.435 · Cited by 317
The role of filaggrin in atopic dermatitis and allergic disease
Drislane, C., & Irvine, A. D. (2020) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.10.008 · Cited by 311
Brough, H. A., Simpson, A., Makinson, K., Hankinson, J., Brown, S., Douiri, A., Belgrave, D. C. M., Penagos, M., Stephens, A. C., McLean, W. H. I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.011 · Cited by 286
Racial differences in atopic dermatitis
Brunner, P. M., & Guttman-Yassky, E. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.11.015 · Cited by 282
Psychological and educational interventions for atopic eczema in children
Ersser, S. J., Cowdell, F., Latter, S., Gardiner, E., Flohr, C., Thompson, A. R., Jackson, K., Farasat, H., Ware, F., & Drury, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004054.pub3 · Cited by 265
Amano, W., Nakajima, S., Kunugi, H., Numata, Y., Kitoh, A., Egawa, G., Dainichi, T., Honda, T., Otsuka, A., Kimoto, Y., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.051 · Cited by 259
Czarnowicki, T., Krueger, J. G., & Guttman-Yassky, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.004 · Cited by 260
Flohr, C., England, K., Radulovic, S., McLean, W. H. I., Campbell, L. E., Barker, J., Perkin, M., & Lack, G. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10068.x · Cited by 251
Gutowska-Owsiak, D., Schaupp, A. L., Salimi, M., Taylor, S., & Ogg, G. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10400.x · Cited by 168
Effect of moisturizers on epidermal barrier function
Lodén, M. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.08.015 · Cited by 161
Filaggrin Gene Defects and the Risk of Developing Allergic Disorders
Osawa, R., Akiyama, M., & Shimizu, H. (2011) · Allergology International · doi:10.2332/allergolint.10-rai-0270 · Cited by 135
Atopic dermatitis: a candidate for disease‐modifying strategy
Bieber, T., Cork, M., & Reitamo, S. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02845.x · Cited by 131
“As this particular form of AD is considered as the initial step of the atopic march (34–37) and FLG null mutations have been reproducibly associated with AD followed by allergic asthma (38, 39), it seems reasonable to suggest that FLG will represent the first important prognostic marker for atopic march in early infan…”
BackgroundNatural History and Risk Factors of Atopic Dermatitis in Children
Pyun, B. Y. (2015) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2015.7.2.101 · Cited by 115
Genetics and epigenetics of atopic dermatitis: an updated systematic review
Martin, M. J., Estravís, M., García-Sánchez, A., Dávila, I., Isidoro-García, M., & Sanz, C. (2020) · Genes · doi:10.3390/genes11040442 · Cited by 99
Sargen, M. R., Hoffstad, O., & Margolis, D. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.274 · Cited by 99
Abnormal epidermal barrier in the pathogenesis of atopic dermatitis
Wolf, R., & Wolf, D. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.08.023 · Cited by 87
Chiu, C.-Y., Huang, Y.-L., Tsai, M.-H., Tu, Y.-L., Hua, M.-C., Yao, T.-C., Yeh, K.-W., & Huang, J.-L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102809 · Cited by 85
Park, J., Jekarl, D. W., Kim, Y., Kim, J., Kim, M., & Park, Y. M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12935 · Cited by 50
Moisturizers for Patients with Atopic Dermatitis: An Overview
Sirikudta, W. (2013) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000143 · Cited by 19
“Additionally, Loss-of-function mutations in filaggrin gene are risk factors in developing this disease [5].”
BackgroundUnderstanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases
Jiménez‐Saiz, R., Iborra, S., Blanco, C., González‐Pérez, R., Nuñez‐Borque, E., Zeyneloglu, C., Babayev, H., Göksel, O., Göksel, T., Khaitov, M., et al. (2026) · Allergy · doi:10.1111/all.70512 · Cited by 2
Metadata
- Authors
- van den Oord, R. A. H. M., & Sheikh, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-07-09
- Volume
- 339
- Issue
- jul08 4
- Pages
- b2433-b2433
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2134317330
- Cited by
- 467
- References
- 16
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.